GenArraytion, Inc. is developing products and services for rapid diagnosis of infectious disease
agents, including those underlying sepsis and hospital-acquired infections. The GenArraytion Team
has extensive experience developing signatures for high confidence pathogen identification and
determination of virulence mechanisms and antibiotic susceptibility in a single test. Our novel
approach enables us to rapidly develop and produce high fidelity, high throughput diagnostics for
a wide range of infectious disease-related conditions, including those that are newly emerging or
poorly characterized.
GenArraytion provides a paradigm-shifting approach to the medical
community that will dramatically impact the quality and speed of infectious disease diagnosis
and, thus, the quality and speed of
medical treatment. Increasing frequency and severity of disease resulting from pathogens such as
MRSA and tuberculosis with resistance to multiple antibiotics have created an urgent need for
improved diagnostic methods. Our high fidelity pathogen signatures identify infectious disease
agents and their antibiotic susceptibility in a fraction of the time required required with
current methods. Our products and services will have high impact in critical care settings resulting
in improved patient outcomes and higher bed turnover that positively impact a hospital's bottom line.